| Literature DB >> 17906120 |
Richard D Cannon1, Erwin Lamping1, Ann R Holmes1, Kyoko Niimi1, Koichi Tanabe2, Masakazu Niimi2, Brian C Monk1.
Abstract
There are relatively few classes of antifungal drugs. This restricts clinicians' therapeutic choices and these choices are further reduced by the emergence of drug resistance. Exposure to antifungal drugs represents an environmental stress for the fungal pathogen Candida albicans. The immediate response of C. albicans to antifungals may be drug tolerance, which can lead to drug resistance. This article examines C. albicans drug resistance from the perspective of it being a stress response and investigates how commonality with other stress-response pathways gives insights into the prospects for overcoming, or preventing, drug resistance.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17906120 DOI: 10.1099/mic.0.2007/010405-0
Source DB: PubMed Journal: Microbiology ISSN: 1350-0872 Impact factor: 2.777